orgalutran
n.v. organon - ганереликс - reproductive techniques, assisted; ovulation induction; infertility, female - Хипофизни и хипоталамични хормони и аналози - Предотвратяване на преждевременно покачване на лутеинизиращия хормон при жени, подложени на контролирана овариална хиперстимулация на техники за асистирана репродукция. В клинични проучвания, orgalutran, използван от рекомбинантный човешкия фолликулостимулирующий хормон или corifollitropin Алфа, постоянен стимулатор на фоликул .
ganirelix gedeon richter
chemical works of gedeon richter plc. (gedeon richter plc.) - ganirelix acetate - reproductive techniques, assisted; ovulation induction; infertility, female - Хипофизни и хипоталамични хормони и аналози - prevention of premature luteinising hormone (lh) surges in women undergoing controlled ovarian hyperstimulation (coh) for assisted reproduction techniques (art).
generalgin 500 mg tablets
Генерика ООД - Метамизол натрий - 500 mg tablets
azpizal 325 mg film - coated tablets
Генерика Информ Импекс ЕООД - Ацетилсалициловата киселина - 325 mg film - coated tablets
reseligo 3,6 mg implant in pre - filled syringe
alvogen ipco.s.ar. i. - Гозерелин - 3,6 mg implant in pre - filled syringe
reseligo 10,8 mg implant in pre - filled syringe
alvogen ipco.s.ar. i. - Гозерелин - 10,8 mg implant in pre - filled syringe
zoladex 3,6 mg implant
astrazeneca pharmaceuticals ab - Гозерелин - 3,6 mg implant
zoladex 10,8 mg implant
astrazeneca pharmaceuticals ab - Гозерелин - 10,8 mg implant
firmagon
ferring pharmaceuticals a/s - дегареликс - Простатни неоплазми - Ендокринна терапия - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
camcevi
accord healthcare s.l.u. - leuprorelin mesilate - Простатни неоплазми - Ендокринна терапия - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.